Redeye provides a research update following the Q3 report recently published by Magle. The company has managed to recover some momentum following the previous delayed high-value orders and financial shortcomings in the Q2 report. However, despite this, the report came in below our expectations in terms of anticipated sales growth.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/